TLR4 and melanoma: For instance, in a murine model of transplanted melanoma, prophylactic application of TLR4/9 agonists (before tumor inoculation) can activate the IFNγ/STAT1 signaling pathway, promoting tumor cell autophagy and autophagy-related tumor cell death, subsequently reducing metastasis.